Health Canada inspection
Bristol-Myers Squibb Company, Inc.: Health Canada inspection of Jun 5, 2019
Health Canada · GMP · rating C
Key facts
| Establishment | Bristol-Myers Squibb Company, Inc. |
|---|---|
| City | East Syracuse |
| Province | NY |
| Country | United States |
| Program | GMP |
| Start date | May 28, 2019 |
| End date | Jun 5, 2019 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.